---
figid: PMC11098888__10620_2024_8392_Fig4_HTML
figtitle: CCL1/CCR8, CCL3/CCR5, CXCL6/CXCR2, and CXCL12/ CXCR4 axes in esophageal
  squamous cell carcinoma
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11098888
filename: PMC11098888__10620_2024_8392_Fig4_HTML.jpg
figlink: /pmc/articles/PMC11098888/figure/F4
number: F4
caption: Schematic model of the CCL1/CCR8, CCL3/CCR5, CXCL6/CXCR2, and CXCL12/ CXCR4
  axes in esophageal squamous cell carcinoma. CCL1 binds to the receptor CCR8 on cancer
  cells, and CCL1/CCR8 interaction promotes cancer cell migration and inhibits cancer
  cell apoptosis by activating Akt signaling pathway. CCL3 promotes tumor progression
  and poor prognosis in esophageal squamous cell carcinoma patients by binding to
  CCR5 on esophageal squamous cell carcinoma cells, activating the PI3K/AKT and MEK/ERK
  pathways, and promoting cell proliferation, migration, and angiogenesis. CXCL6 enhances
  transcription by activating the STAT3 pathway and enhances the growth and metastasis
  of esophageal squamous cell carcinoma cells. CXCL12/CXCR4 is one of the main mechanisms
  that esophageal squamous cell carcinoma cells transfer through ERK1/2 signaling
  pathway
papertitle: 'Chemokines and Their Receptors: Predictors of Therapeutic Potential in
  Tumor Microenvironment on Esophageal Cancer'
reftext: Cong-Gai Huang, et al. Dig Dis Sci. 2024 Apr 5;69(5).
year: '2024'
doi: 10.1007/s10620-024-08392-y
journal_title: Digestive Diseases and Sciences
journal_nlm_ta: Dig Dis Sci
publisher_name: Springer US
keywords: Chemokine | Chemokine receptor | Esophageal cancer | Therapeutic potential
  | Tumor microenvironment
automl_pathway: 0.8696903
figid_alias: PMC11098888__F4
figtype: Figure
redirect_from: /figures/PMC11098888__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11098888__10620_2024_8392_Fig4_HTML.html
  '@type': Dataset
  description: Schematic model of the CCL1/CCR8, CCL3/CCR5, CXCL6/CXCR2, and CXCL12/
    CXCR4 axes in esophageal squamous cell carcinoma. CCL1 binds to the receptor CCR8
    on cancer cells, and CCL1/CCR8 interaction promotes cancer cell migration and
    inhibits cancer cell apoptosis by activating Akt signaling pathway. CCL3 promotes
    tumor progression and poor prognosis in esophageal squamous cell carcinoma patients
    by binding to CCR5 on esophageal squamous cell carcinoma cells, activating the
    PI3K/AKT and MEK/ERK pathways, and promoting cell proliferation, migration, and
    angiogenesis. CXCL6 enhances transcription by activating the STAT3 pathway and
    enhances the growth and metastasis of esophageal squamous cell carcinoma cells.
    CXCL12/CXCR4 is one of the main mechanisms that esophageal squamous cell carcinoma
    cells transfer through ERK1/2 signaling pathway
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SOAT1
  - STAT1
  - STAT2
  - STAT3
  - STAT4
  - STAT6
  - STAT5A
  - STAT5B
  - CCR5
  - CCL3
  - CXCR2
  - CXCL6
  - CXCR4
  - CXCL12
  - CCR8
  - CCL1
  - ADCY1
  - ADCY2
  - ADCY3
  - ADCY4
  - ADCY5
  - ADCY6
  - ADCY7
  - ADCY8
  - ADCY9
  - ADCY10
  - KRAS
  - HRAS
  - NRAS
  - SUCLG2
  - GNB1
  - GNB2
  - GNB3
  - GNB4
  - GNB5
  - GAL
  - GALP
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - MTG1
  - GNAQ
  - SRC
  - FGR
  - FYN
  - YES1
  - RAF1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - PITX2
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - PTK2B
  - PLCB1
  - PLCB2
  - PLCB3
  - PLCB4
  - RAPGEF3
  - RAPGEF4
  - PTEN
  - MAP2K2
  - MAP2K1
  - RAP1A
  - RABGEF1
  - TERF2IP
  - RAP1B
  - PDK1
  - PDK2
  - PDK3
  - PDK4
  - RHO
  - RHOD
  - RHOA
  - RHOB
  - RHOC
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - MAPK3
  - MAPK1
  - PLA2G1B
  - PLA2G2A
  - PLA2G6
  - PLA2G3
  - PLA2G5
  - PLA2G7
  - PLA2G10
  - PLA2G12A
  - PLA2G12B
  - PLA2G2C
  - PLA2G2D
  - PLA2G2E
  - PLA2G2F
  - PLA2G4A
  - PLA2G4C
  - PLA2G4D
  - AKT1
  - AKT2
  - AKT3
  - PTGS2
  - Ras
  - Gal
  - GTP
  - CAMP
  - Prostaglandins
---
